| PhaseOneTrials has conducted many phase I and phase II trials
since it began operations in 2004. Here is a list of selected references
that includes project descriptions as well as client statements. |
| |
|
| |
 |
| Phase I glucose clamp trial. Crossover trial in 34 healthy
subjects. Four six-hour clamps conducted per day. |
| First-in-Man dose escalation trial in 56 healthy subjects
who were hospitalized for up to 10 days. |
| |
| |
|
|
| |
 |
| |
| |
 |
| Phase I sensory evaluation trial in specially trained healthy
subjects. |
| Phase I bioequivalence trial – triple crossover study
in healthy subjects. |
| |
|
|
|
| |
| |
|
| |
| |
 |
| PhaseOneTrials has helped conduct several phase II Proof-of-Concept
trials in various patient populations. |
| |
|
|
|
| |
| |
|
| |
| |
 |
| First-in-Man trial in 60 healthy subjects. |
| Proof-of-Concept phase II trials in patients with osteoporosis. |
| |
|
|
|
| |
| |
|
| |
| |
 |
| Phase I evaluation of a new medicine delivery system –
bioavailability trial in healthy subjects, a quadruple crossover
study. |
| |
|
|
| |
| |
|
| |
| |
 |
| First-in-Man, orphan drug trial in pediatric patients with
a rare enzyme deficiency. |
|
|
| |
| |
|
| |
| |
 |
| Phase I trial in healthy subjects for evaluating bone marrow,
liver, spleen and lymph nodes with the aid of bone marrow biopsies
and MRI scans. |
| Phase II Proof-of-Concept trials in 30 patients with chronic
skin disease. |
| |
|
|
| |
| |
|
| |
| |
|
|  |
 |
